{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:52:51Z","timestamp":1782823971498,"version":"3.54.5"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dadr.2025.100394","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T15:50:49Z","timestamp":1762703449000},"page":"100394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinically characterizing adults who use kava or kratom: Substance use disorder assessment challenges for increasingly popular botanical products"],"prefix":"10.1016","volume":"17","author":[{"given":"Katherine","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dadr.2025.100394_bib1","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00213-024-06646-1","article-title":"Heterogeneity in choice models of addiction: the role of context","volume":"241","author":"Acuff","year":"2024","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0306312710395341","article-title":"Tradition and toxicity: evidential cultures in the kava safety debate","volume":"41","author":"Baker","year":"2011","journal-title":"Soc. Stud. Sci."},{"key":"10.1016\/j.dadr.2025.100394_bib3","unstructured":"Bellamy, C. (2025, August 12). On TikTok, warnings spread about the herbal tonic \u201cFeel Free.\u201d NBC News. \u3008https:\/\/www.nbcnews.com\/health\/health-news\/tiktok-warnings-spread-herbal-tonic-feel-free-rcna223179\u3009"},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/dmd.121.000640","article-title":"The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study","volume":"50","author":"Berthold","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.dadr.2025.100394_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2025.06.016","article-title":"Severe kava withdrawal managed with phenobarbital","author":"Bleifuss","year":"2025","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom ( Mitragynia speciosa korth","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.dadr.2025.100394_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/ADM.0000000000001314","article-title":"Kava Withdrawal Treated With Phenobarbital\u2014A Case Report and Literature Review","volume":"18","author":"Cassidy","year":"2024","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157700","article-title":"Kavain, the major constituent of the anxiolytic kava extract, potentiates GABAA receptors: functional characteristics and molecular mechanism","volume":"11","author":"Chua","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dadr.2025.100394_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/968786","article-title":"Following \u201cthe Roots\u201d of Kratom ( Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in southeast asia to a recreational psychoactive drug in western countries","volume":"2015","author":"Cinosi","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2003.07.005","article-title":"Kava kava: Examining new reports of toxicity","volume":"150","author":"Clouatre","year":"2004","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/713659370","article-title":"Kava in Arnhem Land: A review of consumption and its social correlates","volume":"19","author":"Clough","year":"2000","journal-title":"Drug Alcohol Rev."},{"issue":"4","key":"10.1016\/j.dadr.2025.100394_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/10550887.2020.1788914","article-title":"Prevalence and characteristics of self-reported kratom use in a representative US general population sample","volume":"38","author":"Covvey","year":"2020","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.dadr.2025.100394_bib13","series-title":"Islands, plants, and Polynesians: An introduction to Polynesian ethnobotany proceedings of a symposium sponsored","author":"Cox","year":"1991"},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0773.1992.tb00530.x","article-title":"Kava Pyrones and Resin: Studies on GABAA, GABAB and Benzodiazepine Binding Sites in Rodent Brain","volume":"71","author":"Davies","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.dadr.2025.100394_bib15","author":"Davis","year":"1999","journal-title":"Kava (Pipe methysticum) South Pac. Import. Methods Cultiv. Cultiv. Dis. Pests"},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/hep.27612","article-title":"Cholestatic hepatitis from prolonged kratom use: A case report","volume":"61","author":"Dorman","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dadr.2025.100394_bib17","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.75654","article-title":"The Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults","author":"Dufour","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.dadr.2025.100394_bib18","series-title":"In Pacific Social Work","article-title":"Getting on the K.A.D.: The impacts of kava, alcohol and other drug consumption across Pacific communities","author":"Faleolo","year":"2019"},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40429-023-00466-7","article-title":"Omissions, ambiguities, and underuse of causal assessment tools: a systematic review of case reports on patients who use kratom","volume":"10","author":"Feldman","year":"2023","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.dadr.2025.100394_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2024.2424278","article-title":"Kratom Consumption \u2013 the tales of three patients","author":"Gnanasegaram","year":"2024","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.dadr.2025.100394_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2017.03.007","article-title":"Patterns of Kratom use and health impact in the US\u2014Results from an online survey","volume":"176","author":"Grundmann","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100394_bib22","article-title":"Not all kratom is equal: The important distinction between native leaf and extract products","author":"Grundmann","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2025.100394_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2025.2474249","article-title":"Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample","author":"Grundmann","year":"2025","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.dadr.2025.100394_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001290","article-title":"Prevalence of Kratom Use Disorder among Kratom Consumers","author":"Hill","year":"2024","journal-title":"J. Addict. Med."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00952990.2024.2414319","article-title":"At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use","volume":"51","author":"Hill","year":"2025","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.dadr.2025.100394_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112701","article-title":"De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing","volume":"272","author":"Hill","year":"2025","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100394_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.dadr.2025.100394_bib28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/acs.jnatprod.3c00092","article-title":"Metabolite and molecular characterization of mitragyna speciosa identifies developmental and genotypic effects on monoterpene indole and oxindole alkaloid composition","volume":"86","author":"Laforest","year":"2023","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.15288\/qjsa.1967.28.328","article-title":"Secular Use of Kava in Tonga","volume":"28","author":"Lemert","year":"1967","journal-title":"Q. J. Stud. Alcohol"},{"issue":"18","key":"10.1016\/j.dadr.2025.100394_bib30","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1021\/acs.jmedchem.1c00726","article-title":"Activity of Mitragyna speciosa (\u201cKratom\u201d) Alkaloids at Serotonin Receptors","volume":"64","author":"Le\u00f3n","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/cts.13505","article-title":"An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021","volume":"16","author":"Li","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: Contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.dadr.2025.100394_bib33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1055\/a-1212-5475","article-title":"Pharmacokinetics and safety of mitragynine in beagle dogs","volume":"86","author":"Maxwell","year":"2020","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17512433.2024.2305798","article-title":"An update on the clinical pharmacology of kratom: Uses, abuse potential, and future considerations","volume":"17","author":"McCurdy","year":"2024","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/713659319","article-title":"Kava in the Pacific Islands: a contemporary drug of abuse?","volume":"19","author":"Mcdonald","year":"2000","journal-title":"Drug Alcohol Rev."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc -opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.amepre.2021.02.004","article-title":"Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample","volume":"61","author":"Palamar","year":"2021","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2025.100394_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2025.100361","article-title":"Kratom use among ethnobotanical tea bar patrons in Colorado: subjective drug effects, adverse reactions, and perceived benefits of use","author":"Piercey","year":"2025","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.dadr.2025.100394_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003383","article-title":"Kava extract versus placebo for treating anxiety","author":"Pittler","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.dadr.2025.100394_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41477-019-0474-0","article-title":"The biosynthetic origin of psychoactive kavalactones in kava","volume":"5","author":"Pluskal","year":"2019","journal-title":"Nat. Plants"},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/00952990.2022.2140292","article-title":"Kava ( Piper methysticum) in the United States: the quiet rise of a substance with often subtle effects","volume":"49","author":"Pont-Fernandez","year":"2023","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12954-015-0080-z","article-title":"A response for substance and harm reduction in Pacific Island countries and territories","volume":"12","author":"Power","year":"2015","journal-title":"Harm Reduct. J."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib43","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00213-024-06734-2","article-title":"An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans","volume":"242","author":"Prevete","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.dadr.2025.100394_bib44","unstructured":"Reddy, S. (2025, August 16). What You Need to Know About Kratom. Wall Street Journal. \u3008https:\/\/www.wsj.com\/health\/wellness\/kratom-supplement-safety-b63d0573\u3009"},{"key":"10.1016\/j.dadr.2025.100394_bib45","unstructured":"Reissig, C., Setnik, B., Milovan, D., McCurdy, C., Sharma, A., Hawkins, G., Bonson, K., Galati, S., & Chiapperino, D. (2024, June). A pilot, placebo controlled, dose-finding, pharmacodynamic and pharmacokinetic study of orally administered botanical kratom in non-dependent, recreational polydrug users with opioid experience under fed conditions [Poster]. CPDD. \u3008https:\/\/static1.squarespace.com\/static\/6508b3f79033221c2aa1ea17\/t\/675332c4b06fcf63861b48b4\/1733505733435\/Reissig%2BCPDD%2B2024_FINAL.pdf\u3009"},{"key":"10.1016\/j.dadr.2025.100394_bib46","article-title":"For better or worse: self-reported changes in kratom and other substance use as a result of the COVID-19 Pandemic","volume":"16","author":"Rogers","year":"2022","journal-title":"Subst. Abus. Res. Treat."},{"key":"10.1016\/j.dadr.2025.100394_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111329","article-title":"Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency","volume":"260","author":"Rogers","year":"2024","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/08897077.2019.1671945","article-title":"Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: a case report in a young adult","volume":"41","author":"Schmuhl","year":"2020","journal-title":"Subst. Abus."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12110-014-9191-6","article-title":"How does male ritual behavior vary across the lifespan?: an examination of fijian kava ceremonies","volume":"25","author":"Shaver","year":"2014","journal-title":"Hum. Nat."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02791072.2015.1012610","article-title":"Social functioning of kratom (Mitragyna speciosa) Users in Malaysia","volume":"47","author":"Singh","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.dadr.2025.100394_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainresbull.2016.05.004","article-title":"Traditional and non-traditional uses of Mitragynine (Kratom): a survey of the literature","volume":"126","author":"Singh","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2582","article-title":"Changing trends in the use of kratom ( Mitragyna speciosa) in Southeast Asia","volume":"32","author":"Singh","year":"2017","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/2405461503666180420120649","article-title":"Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia","volume":"8","author":"Singh","year":"2019","journal-title":"Curr. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/ADM.0000000000000876","article-title":"The Use of Kratom (Mitragyna speciosa Korth.) among people who co-use heroin and methamphetamine in Malaysia","volume":"16","author":"Singh","year":"2022","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib55","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/ADM.0000000000000986","article-title":"Assessment of kratom use disorder and withdrawal among an online convenience sample of US Adults","volume":"16","author":"Smith","year":"2022","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100394_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.765917","article-title":"Searching for a signal: self-reported kratom dose-effect relationships among a sample of us adults with regular kratom use histories","volume":"13","author":"Smith","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/00952990.2022.2083967","article-title":"Kratom use as more than a \u201cself-treatment","volume":"48","author":"Smith","year":"2022","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s40429-023-00476-5","article-title":"Kratom\u2019s Emergence and persistence within the US polydrug epidemic","volume":"10","author":"Smith","year":"2023","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.dadr.2025.100394_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1174139","article-title":"Examining the paradoxical effects of kratom: A narrative inquiry","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s40429-023-00474-7","article-title":"Diagnostic ambiguities and underuse of clinical assessment tools: a systematic review of case reports on kratom addiction and physical dependence","volume":"10","author":"Smith","year":"2023","journal-title":"Curr. Addict. Rep."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/ADM.0000000000001259","article-title":"Responses to a \u201ctypical\u201d morning dose of kratom in people who use kratom regularly: a direct-observation study","volume":"18","author":"Smith","year":"2024","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53401","article-title":"Ecological momentary assessment of self-reported kratom use, effects, and motivations among US Adults","volume":"7","author":"Smith","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100394_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.112460","article-title":"Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content","volume":"264","author":"Smith","year":"2024","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.dadr.2025.100394_bib64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11920-024-01524-1","article-title":"Controversies in assessment, diagnosis, and treatment of kratom use disorder","volume":"26","author":"Smith","year":"2024","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/add.16728","article-title":"The rise of novel, semi-synthetic 7-hydroxymitragnine products","volume":"120","author":"Smith","year":"2025","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s13181-024-01016-x","article-title":"Neonatal and maternal ichthyosiform dermopathy in association with kava use during pregnancy","volume":"20","author":"Spungen","year":"2024","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib67","first-page":"54","article-title":"Pharmacotherapy for management of \u201ckratom use disorder\u201d: a systematic literature review with survey of experts","volume":"120","author":"Stanciu","year":"2021","journal-title":"WMJ Off. Publ. State Med. Soc. Wis."},{"issue":"1","key":"10.1016\/j.dadr.2025.100394_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-013-3201-y","article-title":"Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract","volume":"231","author":"Stolt","year":"2014","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.dadr.2025.100394_bib69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ADM.0000000000001328","article-title":"Isolated Kratom use disorder treated with extended-release buprenorphine taper","volume":"18","author":"Swart","year":"2024","journal-title":"J. Addict. Med."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib70","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/pharmaceutics14030620","article-title":"Clinical pharmacokinetic assessment of kratom (mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants","volume":"14","author":"Tanna","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.dadr.2025.100394_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15286\/jps.129.2.171-192","article-title":"The past before us: A brief history of Tongan kava","volume":"129","author":"Tecun","year":"2020","journal-title":"J. Polyn. Soc."},{"issue":"9","key":"10.1016\/j.dadr.2025.100394_bib72","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1478-3231.2010.02308.x","article-title":"Kava hepatotoxicity: Pathogenetic aspects and prospective considerations: Kava hepatotoxicity","volume":"30","author":"Teschke","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.dadr.2025.100394_bib73","unstructured":"US Association Initiates Partnership In Kratom Export With Indonesia. (2022). Kantor Staf Presiden. \u3008https:\/\/www.ksp.go.id\/en\/us-association-initiates-partnership-in-kratom-export-with-indonesia.html\u3009"},{"issue":"6","key":"10.1016\/j.dadr.2025.100394_bib74","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11011-019-00477-2","article-title":"Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism","volume":"34","author":"Vijeepallam","year":"2019","journal-title":"Metab. Brain Dis."},{"issue":"23","key":"10.1016\/j.dadr.2025.100394_bib75","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1021\/acschemneuro.9b00587","article-title":"DARK classics in chemical neuroscience: kava","volume":"11","author":"Volgin","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.dadr.2025.100394_bib76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-9422(03)00381-9","article-title":"Kava lactones and the kava-kava controversy","volume":"64","author":"Whitton","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.dadr.2025.100394_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.11.002","article-title":"The effect of mitragynine on extracellular activity of brain dopamine and its metabolites","volume":"178","author":"Yusoff","year":"2022","journal-title":"Brain Res. Bull."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:16:08Z","timestamp":1764850568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":77,"alternative-id":["S2772724625000770"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100394","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically characterizing adults who use kava or kratom: Substance use disorder assessment challenges for increasingly popular botanical products","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100394"}}